Page last updated: 2024-10-17

bupropion and Glaucoma

bupropion has been researched along with Glaucoma in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research Excerpts

ExcerptRelevanceReference
"To investigate the relationship between self-reported bupropion use and self-reported glaucoma in a nationally representative sample of the US population."7.85Association between self-reported bupropion use and glaucoma: a population-based study. ( Kakigi, C; Lin, S; Masís, M; Singh, K, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masís, M1
Kakigi, C1
Singh, K1
Lin, S1

Other Studies

1 other study available for bupropion and Glaucoma

ArticleYear
Association between self-reported bupropion use and glaucoma: a population-based study.
    The British journal of ophthalmology, 2017, Volume: 101, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Bupropion; Comorbidity; Cross-Sectional Studies; Dose-Resp

2017